SciELO - Brasil - CD20 role in pathophysiology of Hodgkin's disease CD20 role in pathophysiology of Hodgkin's disease
Cells | Free Full-Text | Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients | HTML
Frontiers | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
CD antigens expression in B cells
CD20 as a gatekeeper of the resting state of human B cells | PNAS
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Summary of CD19 and CD20 expression during B cell development. CD19... | Download Scientific Diagram
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Surface Levels of CD20 Determine Anti-CD20 Antibodies Mediated Cell Death In Vitro | PLOS ONE
Expression of CD19 and CD20 according to maturation steps. CD19 is... | Download Scientific Diagram
The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
Summary of CD19 and CD20 expression during B cell development. CD19... | Download Scientific Diagram
CD20 as a gatekeeper of the resting state of human B cells | PNAS
CD20 - Wikipedia
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
CD-20 | ドライブレコーダー | セルスター工業株式会社
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children | American Society of Nephrology
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
